Liver function assessment by MEGX: Application to oncology

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 486-490

  Cannizzaro, R ^a   Robieux, I ^a   Valentini, M ^a   Sorio, R ^a   Amoroso, B ^b   Tumolo, S ^a   Campagnutta, E ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ABBOTT DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DEETHYLLIDOCAINE; LIDOCAINE; NAVELBINE; NITROSOUREA;

ADULT; AGED; BREAST CANCER; CONFERENCE PAPER; DEALKYLATION; FEMALE; HUMAN; IMMUNOASSAY; LIVER CANCER; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT MONITORING; PROGNOSIS;

EID: 0029901453     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16268.x     Document Type: Article

References (6)

1. TYGSTRUP, N. 1990. Assessment of liver function: principles and practice. J. Gastroenterol. Hepatol. 5: 468-482.
2. OELLERICH, M. et al. 1990. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther. Drug Monit. 12: 219-226.
3. PERRY, M. C. 1992. Chemotherapeutic agents and hepatotoxicity. Semin. Oncol. 19(5): 551-565.
4. BROCKMOLLER, J. & I. ROOTS. 1994. Assessment of liver metabolic function: clinical implications. Clin. Pharmacokinet. 27(3): 216-248.
5. CANNIZZARO, R. et al. 1994. Monoethylglycine xylidide (MEGX) test in cancer patients with liver metastases. Ital. J. Gastroenterol. 26(9): 37.
6. ROBIEUX, I. 1995. Pharmacokinetics of vinorelbine in patients with liver metastases. Winter Meeting of the PAMM Group, Toulouse, France (12-14 January 1995).